Article
For which infants with viral bronchiolitis could it be deemed appropriate to use albuterol, at least on a therapeutic trial basis?
Allergologia et immunopathologia - 1 Jan 2021
Rodríguez-Martínez Carlos E, Nino Gustavo, Castro-Rodriguez Jose A, Acuña-Cordero Ranniery, Sossa-Briceño Monica P, Midulla Fabio
Abstract excerpt
Although there is increasing evidence showing that infants with viral bronchiolitis exhibit a high degree of heterogeneity, a core uncertainty shared by many clinicians is with regard to understanding which patients are most likely to benefit from bronchodilators such as albuterol. Based on our review, we concluded that older infants with rhinovirus (RV) bronchiolitis, especially those with a nasopharyngeal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
